Abstract

ObjectiveTo investigate the prognostic value of cancer antigen 125 (CA125) related variables on progression free survival and overall survival in primary and recurrent ovarian cancers.MethodA comprehensive review of the Medline,...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Angiogenesis inhibitors for the treatment of epithelial ovarian cancer.
Yifan Chen ... Jo Morrison
The Cochrane database of systematic reviews | VOL. 4
Yifan Chen, et. al.Yifan Chen ... Jo Morrison
18 Apr 2023
Epidermal growth factor receptor blockers for the treatment of ovarian cancer.
Alison J Wiggans ... Andrew Bryant
The Cochrane database of systematic reviews | VOL. 10
Alison J Wiggans, et. al.Alison J Wiggans ... Andrew Bryant
15 Oct 2018
Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.
Jo Morrison ... Abigail Tattersall
The Cochrane database of systematic reviews | VOL. 2
Jo Morrison, et. al.Jo Morrison ... Abigail Tattersall
16 Feb 2022
Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancer.
David Sp Tan ... Ruby Yun-Ju Huang
The Cochrane database of systematic reviews | VOL. 2
David Sp Tan, et. al.David Sp Tan ... Ruby Yun-Ju Huang
21 Feb 2022
View more papers

More From: International Journal of Gynecologic Cancer

Paper Title
Journal
Date
Author
Can international standards in ovarian cancer treatment be attained by low- and middle-income countries?
Daniel Sanabria ... Adriana Ramos
International Journal of Gynecologic Cancer | VOL. -
Daniel Sanabria, et. al.Daniel Sanabria ... Adriana Ramos
24 May 2024
Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancer
Eric Rios-Doria ... Mario M Leitao
International Journal of Gynecologic Cancer | VOL. -
Eric Rios-Doria, et. al.Eric Rios-Doria ... Mario M Leitao
23 May 2024
A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC)
Agnieszka Michael ... Jonathan Ledermann
International Journal of Gynecologic Cancer | VOL. -
Agnieszka Michael, et. al.Agnieszka Michael ... Jonathan Ledermann
17 May 2024
Predictive value of SUVmax from initial 18F-FDG PET/CT scans for treatment outcomes in endometrial cancer patients undergoing fertility sparing management
Ok-Ju Kang ... Jeong-Yeol Park
International Journal of Gynecologic Cancer | VOL. -
Ok-Ju Kang, et. al.Ok-Ju Kang ... Jeong-Yeol Park
16 May 2024
View more papers